AO is thought to account for 20-50% of all oligodendroglial tumors. The majority of these lesions arise in adults with a mean age at operation of 48.7 years. The is a slight male predominance (1.5:1).Localization
Like oligodendrogliomas, AO typically occurs in the cortex and white matter of the cerebral hemispheres, most commonly in the Frontal Lobe.Clinical presentation
Many patients present with a long history of seizures or headache, though the time course of symptoms tends to shorter and the progression of symptoms faster than in patients who present with oligodendroglioma.
AO may appear similar to an oligodendroglioma, though with regions of overt Tumor necrosis.Histopathology
AO is a composed of neoplastic oligodendrocytes with histological features of malignancy, including increased cellularity, marked cytological atypia, and high mitotic activity. Microvascular proliferation and necrosis may be present.Prognosis
Mean survival time following medical and surgical intervention is 3-4 years, with 5- and 10-year survival rates of 41% and 20%, respectively. Risk of Malignant progression is thought to correspond to the astrocytic component of the tumor. Factors though to confer more favorable outcome include young age, chromosomes 1p and 19q deletion, frontal location, gross total surgical resection, and post-operative Karnofsky score.
Example 1: Histopathological image of anaplastic oligodendroglioma in cerebrum. Hematoxylin & eosin stain.
This page was last modified 23:04, 19 April 2009
All text and images are available under the terms of the GNU Free Documentation License.